WO2008108862A3 - Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers and their uses for remote spatially controlled chemical delivery - Google Patents

Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers and their uses for remote spatially controlled chemical delivery Download PDF

Info

Publication number
WO2008108862A3
WO2008108862A3 PCT/US2007/072029 US2007072029W WO2008108862A3 WO 2008108862 A3 WO2008108862 A3 WO 2008108862A3 US 2007072029 W US2007072029 W US 2007072029W WO 2008108862 A3 WO2008108862 A3 WO 2008108862A3
Authority
WO
WIPO (PCT)
Prior art keywords
particle
biocontainers
micropatterned
shielded
remote
Prior art date
Application number
PCT/US2007/072029
Other languages
French (fr)
Other versions
WO2008108862A2 (en
Inventor
David H Gracias
Timothy Gar-Ming Leong
Hongke Ye
Original Assignee
Univ Johns Hopkins
David H Gracias
Timothy Gar-Ming Leong
Hongke Ye
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/491,829 external-priority patent/US8236259B2/en
Application filed by Univ Johns Hopkins, David H Gracias, Timothy Gar-Ming Leong, Hongke Ye filed Critical Univ Johns Hopkins
Priority to CA002656648A priority Critical patent/CA2656648A1/en
Priority to EP07870998A priority patent/EP2037809A4/en
Priority to JP2009518492A priority patent/JP5451385B2/en
Priority to US12/306,423 priority patent/US8246917B2/en
Publication of WO2008108862A2 publication Critical patent/WO2008108862A2/en
Publication of WO2008108862A3 publication Critical patent/WO2008108862A3/en
Priority to US13/589,909 priority patent/US8709829B2/en
Priority to US14/199,258 priority patent/US9005995B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0097Micromachined devices; Microelectromechanical systems [MEMS]; Devices obtained by lithographic treatment of silicon; Devices comprising chips
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Composite Materials (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to a nanoscale or microscale particle for encapsulation and delivery of materials or substances, including, but not limited to, cells, drugs, tissue, gels and polymers contained within the particle, with subsequent release of the therapeutic materials in situ, methods of fabricating the particle by folding a 2D precursor into the 3D particle, and the use of the particle in in-vivo or in-vitro applications The particle can be in any polyhedral shape and its surfaces can have either no perforations or nano/microscale perforations The particle is coated with a biocompatible metal, e g gold, or polymer. e g parvlene, layer and the surfaces and hinges of the particle are made of any metal or polymer combinations.
PCT/US2007/072029 2005-07-22 2007-06-25 Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers and their uses for remote spatially controlled chemical delivery WO2008108862A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA002656648A CA2656648A1 (en) 2006-06-23 2007-06-25 Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers and their uses for remote spatially controlled chemical delivery
EP07870998A EP2037809A4 (en) 2006-06-23 2007-06-25 Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers and their uses for remote spatially controlled chemical delivery
JP2009518492A JP5451385B2 (en) 2006-06-23 2007-06-25 Self-organized, micropatterned, radio frequency (RF) blocked biocontainers and their use for remotely and spatially controlled drug delivery
US12/306,423 US8246917B2 (en) 2006-06-23 2007-06-25 Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery
US13/589,909 US8709829B2 (en) 2005-07-22 2012-08-20 Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery
US14/199,258 US9005995B2 (en) 2005-07-22 2014-03-06 Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81606306P 2006-06-23 2006-06-23
US60/816,063 2006-06-23
US11/491,829 US8236259B2 (en) 2005-07-22 2006-07-24 Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers
US11/491,829 2006-07-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/491,829 Continuation-In-Part US8236259B2 (en) 2005-07-22 2006-07-24 Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/306,423 A-371-Of-International US8246917B2 (en) 2005-07-22 2007-06-25 Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery
US13/589,909 Division US8709829B2 (en) 2005-07-22 2012-08-20 Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery

Publications (2)

Publication Number Publication Date
WO2008108862A2 WO2008108862A2 (en) 2008-09-12
WO2008108862A3 true WO2008108862A3 (en) 2008-11-06

Family

ID=39738947

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/072029 WO2008108862A2 (en) 2005-07-22 2007-06-25 Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers and their uses for remote spatially controlled chemical delivery

Country Status (4)

Country Link
EP (1) EP2037809A4 (en)
JP (1) JP5451385B2 (en)
CA (1) CA2656648A1 (en)
WO (1) WO2008108862A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013013328A (en) * 2009-10-30 2013-01-24 Univ Of Tokyo Device having foldable structural body
US9630178B2 (en) * 2010-03-17 2017-04-25 Ut-Battelle, Llc Method for preparing small volume reaction containers
US20140341975A1 (en) * 2011-08-26 2014-11-20 Vicoy Nanomedicines Ltd Pathogen and substance traps
US9058552B2 (en) 2011-10-26 2015-06-16 International Business Machines Corporation RFID tag temperature adaptation
US11331085B2 (en) * 2014-10-16 2022-05-17 The Johns Hopkins University Bioresorbable self-folding tools for surgery, single cell capture and manipulation
JP6786120B2 (en) * 2016-08-17 2020-11-18 国立研究開発法人物質・材料研究機構 Cell encapsulation method and encapsulating cells

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2369392A (en) * 1942-07-21 1945-02-13 Nat Folding Box Co Hinged cover container
US5688486A (en) * 1992-02-11 1997-11-18 Nycomed Salutar, Inc. Use of fullerenes in diagnostic and/or therapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007014113A2 (en) * 2005-07-22 2007-02-01 Johns Hopkins University Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2369392A (en) * 1942-07-21 1945-02-13 Nat Folding Box Co Hinged cover container
US5688486A (en) * 1992-02-11 1997-11-18 Nycomed Salutar, Inc. Use of fullerenes in diagnostic and/or therapeutic agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GEORGAKILAS V. ET AL.: "Supramolecular self-assembled fullerene nanostructures", PNAS, vol. 99, no. 8, 16 April 2002 (2002-04-16), pages 5075 - 5080, XP008101173 *

Also Published As

Publication number Publication date
JP2009541490A (en) 2009-11-26
EP2037809A2 (en) 2009-03-25
JP5451385B2 (en) 2014-03-26
CA2656648A1 (en) 2008-09-12
WO2008108862A2 (en) 2008-09-12
EP2037809A4 (en) 2012-11-21

Similar Documents

Publication Publication Date Title
WO2007014113A3 (en) Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers
Zare et al. Metal-based nanostructures/PLGA nanocomposites: antimicrobial activity, cytotoxicity, and their biomedical applications
Scheibe et al. Cytotoxicity assessment of Ti–Al–C based MAX phases and Ti3C2T x MXenes on human fibroblasts and cervical cancer cells
Xing et al. Two-dimensional MXene (Ti3C2)-integrated cellulose hydrogels: toward smart three-dimensional network nanoplatforms exhibiting light-induced swelling and bimodal photothermal/chemotherapy anticancer activity
Xu et al. Electrostatically assembled multilayered films of biopolymer enhanced nanocapsules for on-demand drug release
Hao et al. Tannic acid–silver dual catalysis induced rapid polymerization of conductive hydrogel sensors with excellent stretchability, self-adhesion, and strain-sensitivity properties
Yao et al. Mesoporous silica nanoparticles capped with graphene quantum dots for potential chemo–photothermal synergistic cancer therapy
WO2008108862A3 (en) Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers and their uses for remote spatially controlled chemical delivery
Lam et al. Nanodiamond-embedded microfilm devices for localized chemotherapeutic elution
Zhou et al. Thermoresponsive layer-by-layer assemblies for nanoparticle-based drug delivery
Zhang et al. Recent advances in the synthesis of spherical and nanoMOF-derived multifunctional porous carbon for nanomedicine applications
Wei et al. Preparation of hierarchical hollow CaCO3 particles and the application as anticancer drug carrier
Tian et al. Facile, one-pot synthesis, and antibacterial activity of mesoporous silica nanoparticles decorated with well-dispersed silver nanoparticles
Chen et al. Construction of homogenous/heterogeneous hollow mesoporous silica nanostructures by silica-etching chemistry: principles, synthesis, and applications
Chen et al. Engineering fluorescent poly (dopamine) capsules
Grumezescu Nanoarchitectonics in Biomedicine
Bose et al. Synthesis and characterization of hydroxyapatite nanopowders by emulsion technique
Chen et al. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery
Nedelcu et al. Silver based materials for biomedical applications
Aziz et al. Manufactures of bio‐degradable and bio‐based polymers for bio‐materials in the pharmaceutical field
Xiong et al. Compartmentalized multilayer hydrogel formation using a stimulus-responsive self-assembling polysaccharide
Shi et al. Targeted delivery of hemostats to complex bleeding wounds with magnetic guidance for instant hemostasis
WO2010087912A8 (en) Hydrogels crosslinked with gold nanoparticles
WO2005084637A3 (en) Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof
Kim et al. Performance of NIR-mediated antibacterial continuous flow microreactors prepared by mussel-inspired immobilization of Cs0. 33WO3 photothermal agents

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07870998

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2656648

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009518492

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: RU

REEP Request for entry into the european phase

Ref document number: 2007870998

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007870998

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12306423

Country of ref document: US